JP2014533518A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533518A5
JP2014533518A5 JP2014542951A JP2014542951A JP2014533518A5 JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5 JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5
Authority
JP
Japan
Prior art keywords
polypeptide
ugt
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533518A (ja
JP6084983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/002857 external-priority patent/WO2013076577A1/en
Publication of JP2014533518A publication Critical patent/JP2014533518A/ja
Publication of JP2014533518A5 publication Critical patent/JP2014533518A5/ja
Application granted granted Critical
Publication of JP6084983B2 publication Critical patent/JP6084983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542951A 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料 Active JP6084983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161563303P 2011-11-23 2011-11-23
US61/563,303 2011-11-23
PCT/IB2012/002857 WO2013076577A1 (en) 2011-11-23 2012-11-19 Methods and materials for enzymatic synthesis of mogroside compounds

Publications (3)

Publication Number Publication Date
JP2014533518A JP2014533518A (ja) 2014-12-15
JP2014533518A5 true JP2014533518A5 (enExample) 2016-09-29
JP6084983B2 JP6084983B2 (ja) 2017-02-22

Family

ID=47624376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014542951A Active JP6084983B2 (ja) 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料

Country Status (14)

Country Link
US (2) US9920349B2 (enExample)
EP (1) EP2783009B1 (enExample)
JP (1) JP6084983B2 (enExample)
KR (1) KR101791597B1 (enExample)
CN (1) CN103958693B (enExample)
AU (2) AU2012342114B2 (enExample)
BR (1) BR112014012543A2 (enExample)
CA (1) CA2853677C (enExample)
IN (1) IN2014CN03557A (enExample)
MX (1) MX342851B (enExample)
MY (1) MY170686A (enExample)
RU (1) RU2633644C2 (enExample)
SG (1) SG11201401927PA (enExample)
WO (1) WO2013076577A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101971818B1 (ko) 2010-06-02 2019-04-23 에볼바, 인크. 스테비올 글리코시드의 재조합 생산
EP3009508B1 (en) 2011-08-08 2020-11-25 Evolva SA Recombinant production of steviol glycosides
JP6084983B2 (ja) 2011-11-23 2017-02-22 エヴォルヴァ エスアー.Evolva Sa. モグロシド化合物の酵素的合成のための方法および材料
TW201402599A (zh) * 2012-05-30 2014-01-16 Suntory Holdings Ltd 甜菊糖苷糖苷轉化酵素及編碼該酵素之基因
US9932619B2 (en) 2012-12-04 2018-04-03 Evolva Sa Methods and materials for biosynthesis of mogroside compounds
CA2900882A1 (en) 2013-02-11 2014-08-14 Evolva Sa Efficient production of steviol glycosides in recombinants hosts
KR20170041209A (ko) 2014-08-11 2017-04-14 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 생성
MY191735A (en) 2014-09-09 2022-07-13 Evolva Sa Production of steviol glycosides in recombinant hosts
US20170283844A1 (en) 2014-09-11 2017-10-05 The State of Israel, Ministry of Agriculture & Rural Development, Argricultural Research Organiza Methods of producing mogrosides and compositions comprising same and uses thereof
JP2017529860A (ja) 2014-10-01 2017-10-12 エヴォルヴァ エスアー.Evolva Sa. モグロシド化合物の生合成のための方法および材料
CA2968331C (en) 2014-10-17 2024-02-06 Suntory Holdings Limited Mogrol glycosyltransferase and gene encoding same
EP3249044A4 (en) 2015-01-20 2018-11-07 Suntory Holdings Limited Method for preparing mogroside
CA2973674A1 (en) 2015-01-30 2016-08-04 Evolva Sa Production of steviol glycosides in recombinant hosts
CN115851470B (zh) 2015-03-16 2025-09-02 帝斯曼知识产权资产管理有限公司 Udp-糖基转移酶
MX2018001620A (es) 2015-08-07 2018-06-11 Evolva Sa Produccion de glucosidos de esteviol en hospedadores recombinantes.
HK1258515A1 (zh) 2015-10-29 2019-11-15 赛诺米克斯公司 高强度甜味剂
CN106924274B (zh) * 2015-12-29 2019-01-04 成都普睿法药物研发有限公司 葫芦烷型四环三萜类化合物抗肺纤维化应用
WO2017178632A1 (en) 2016-04-13 2017-10-19 Evolva Sa Production of steviol glycosides in recombinant hosts
CN109312378A (zh) 2016-05-16 2019-02-05 埃沃尔瓦公司 在重组宿主中产生甜菊醇糖苷
AU2017267214A1 (en) * 2016-05-16 2018-11-15 Evolva Sa Production of steviol glycosides in recombinant hosts
EP3502265B1 (en) 2016-07-19 2020-12-02 Suntory Holdings Limited Method for producing mogrol or mogrol glycoside
EP3535406A1 (en) 2016-11-07 2019-09-11 Evolva SA Production of steviol glycosides in recombinant hosts
MX2019012940A (es) * 2017-05-03 2019-12-16 Firmenich Incorporated Metodos para producir edulcorantes de alta intensidad.
WO2018213683A1 (en) 2017-05-19 2018-11-22 The Coca-Cola Company Siamenoside i sweetened compositions and uses of the same
CN116941752A (zh) 2017-06-02 2023-10-27 奇华顿股份有限公司 组合物
WO2018229283A1 (en) 2017-06-15 2018-12-20 Evolva Sa Production of mogroside compounds in recombinant hosts
CN107189976B (zh) * 2017-07-28 2022-03-11 李华政 促进罗汉果ugt72b21基因表达的方法
CA3118467A1 (en) 2018-11-07 2020-05-14 Firmenich Incorporated Methods for making high intensity sweeteners
EP3860363A1 (en) 2018-11-07 2021-08-11 Firmenich Incorporated Methods for making high intensity sweeteners
WO2020097588A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
CN110669094B (zh) * 2019-10-14 2021-12-21 上海交通大学 罗汉果新苷及其制备方法
KR102362135B1 (ko) * 2019-10-25 2022-02-14 고려대학교 산학협력단 테르펜 당쇄 부가 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 조성물
JP2023523886A (ja) * 2020-03-17 2023-06-08 ザ コカ・コーラ カンパニー 新規モグロシド製造システム及び方法
EP4138574A1 (en) 2020-04-20 2023-03-01 Givaudan SA Compositions
GB202007984D0 (en) 2020-05-28 2020-07-15 Givaudan Sa Compositions
CN112063647B (zh) * 2020-09-17 2023-05-02 云南农业大学 酿酒酵母重组菌Cuol01的构建方法、酿酒酵母重组菌Cuol02及应用
CN116064712B (zh) * 2022-10-08 2025-05-06 中国药科大学 一种罗汉果醇的生物合成方法
WO2024218244A1 (en) 2023-04-20 2024-10-24 Dsm Ip Assets B.V. Strains and methods for the production of mogrosides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT
EP1510573A1 (en) * 2003-09-01 2005-03-02 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Method for detoxification of mycotoxins
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US8257948B1 (en) * 2011-02-17 2012-09-04 Purecircle Usa Method of preparing alpha-glucosyl Stevia composition
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
RU2008123259A (ru) 2005-11-23 2009-12-27 Дзе Кока-Кола Компани (US) Композиция интенсивного подсластителя с противовоспалительным средством и подслащенные ею композиции
US7927851B2 (en) 2006-03-21 2011-04-19 Vineland Research And Innovation Centre Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same
WO2008062165A2 (en) * 2006-11-22 2008-05-29 The University Of York Monoterpenoid modifying enzymes
WO2008065370A2 (en) 2006-12-01 2008-06-05 The University Of York Sesquiterpenoid modifying enzymes
GB0904639D0 (en) * 2009-03-18 2009-04-29 Univ York Assay
KR101971818B1 (ko) 2010-06-02 2019-04-23 에볼바, 인크. 스테비올 글리코시드의 재조합 생산
JP6084983B2 (ja) 2011-11-23 2017-02-22 エヴォルヴァ エスアー.Evolva Sa. モグロシド化合物の酵素的合成のための方法および材料
US9932619B2 (en) 2012-12-04 2018-04-03 Evolva Sa Methods and materials for biosynthesis of mogroside compounds

Similar Documents

Publication Publication Date Title
JP2014533518A5 (enExample)
Schoeman et al. Coronavirus envelope protein: current knowledge
Duan et al. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens
Tsai et al. Baculovirus as versatile vectors for protein display and biotechnological applications
JP2018520997A5 (enExample)
JP2012095652A5 (enExample)
JP2012531208A5 (enExample)
Maeda et al. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9)
EP2385107A8 (en) Lentiviral vector based immunological compounds against malaria
Florian et al. Characterization of the anti‐HBV activity of HLP1–23, a human lactoferrin‐derived peptide
Berglund et al. Viral alteration of cellular translational machinery increases defective ribosomal products
Molouki et al. The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain
RU2015148190A (ru) Слитые полипептиды и вакцины
CN102311500B (zh) 一种抗病毒融合蛋白及其应用
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN104404005A (zh) 禽流感病毒ha基因重组腺病毒的制备方法
Liang et al. The role of F1 ATP synthase beta subunit in WSSV infection in the shrimp, Litopenaeus vannamei
CN114736293B (zh) SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用
JP2010279373A5 (enExample)
Zhu et al. Transcription and identification of a novel envelope protein (VP124) gene of shrimp white spot syndrome virus
Jie et al. The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24
Chen et al. Characterization of a novel envelope protein WSV010 of shrimp white spot syndrome virus and its interaction with a major viral structural protein VP24
JP2011530277A5 (enExample)
US20230302083A1 (en) Highly-networked coronavirus immunogen composition
Echeverry et al. Sequence analysis and expression of the polyhedrin gene of Choristoneura fumiferana cytoplasmic polyhedrosis virus (CfCPV)